White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients

Journal of Clinical Psychiatry

Volumn 72, Issue 1, 2011, Pages 104-112

  Oudega, Mardien L ^a   Van Exel, Eric ^a   Wattjes, Mike P ^a   Comijs, Hannie C ^a   Scheltens, Philip ^a   Barkhof, Frederik ^a   Eikelenboom, Piet ^a,b   De Craen, Anton J M ^c   Beekman, Aartjan T F ^a   Stek, Max L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; COHORT ANALYSIS; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; TEMPORAL LOBE; TREATMENT RESPONSE; WHITE MATTER;

AGED; ANTIDEPRESSIVE AGENTS; ATROPHY; BRAIN; CEREBRAL CORTEX; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 79551571112     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04989blu     Document Type: Article

References (42)

1. Dombrovski AJ, Mulsant BH. ECT: the preferred treatment for severe depression in late life [comment]. In: For debate: the evidence for electroconvulsive therapy in the treatment of severe late-life depression. Int Psychogeriatr. 2007;19:19-35.
2. Tew JD Jr, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999;156(12):1865-1870.
3. Steffens DC, Conway CR, Dombeck CB, et al. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. J ECT. 2001;17(1):45-49. doi:10.1097/0124509-201030-09 (Pubitemid 32246865)
4. Farkas E, de Vos RA, Donka G, et al. Age-related microvascular degeneration in the human cerebral periventricular white matter. Acta Neuropathol. 2006;111(2):150-157. doi:10.107/s0401-05-07-y
5. Coffey CE, Figiel GS, Djang WT, et al. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry. 1988;24(2):143-161. doi:10.1016/06-323(8)90270-3
6. Coffey CE, Figiel GS, Djang WT, et al. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci. 1989;1(2):135-144. (Pubitemid 19247957)
7. Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry. 1997;154(4):562-565.
8. Hickie I, Scott E, Mitchell P, et al. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37(3):151-160. doi:10.1016/06-323(94)0174-2
9. Alexopoulos GS, Meyers BS, Young RC, et al. Recovery in geriatric depression. Arch Gen Psychiatry. 1996;53(4):305-312.
10. Krishnan KRR, Hays JC, George LK, et al. Six-month outcomes for MRI-related vascular depression. Depress Anxiety. 1998;8(4):142-146. doi:10.102/(SICI)1520-6394(198)8:4<142:AID-DA2>3.0.CO;2-N (Pubitemid 29016523)
11. Simpson S, Baldwin RC, Jackson A, et al. Is subcortical disease associated with a poor response to antidepressants? neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med. 1998;28(5):1015-1026. doi:10.1017/S032917980693X (Pubitemid 28458458)
12. Steffens DC, Byrum CE, McQuoid DR, et al. Hippocampal volume in geriatric depression. Biol Psychiatry. 2000;48(4):301-309. doi:10.1016/S06-323(0)0829-5
13. Hsieh MH, McQuoid DR, Levy RM, et al. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry. 2002;17(6):519-525. doi:10.102/gps.61 (Pubitemid 34678703)
14. Lekwauwa RE, McQuoid DR, Steffens DC. Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression. Am J Geriatr Psychiatry. 2005;13(10):910-913. (Pubitemid 46638680)
15. National Institute for Clinical Excellence (NICE). Guidance on the Use of Electroconvulsive Therapy. NICE Technology Appraisal Guidance 59. London, England: National Institute for Clinical Excellence; 2003.
16. Farah A, McCall WV. Electroconvulsive therapy stimulus dosing: a survey of contemporary practices. Convuls Ther. 1993;9(2):90-94. (Pubitemid 23198876)
17. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.192/bjp.134.4.382 (Pubitemid 9136500)
18. Corya SA, Andersen SW, Detke HC, et al. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study. J Clin Psychiatry. 2003;64(11):1349-1356. (Pubitemid 37490241)
19. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351-356. (Pubitemid 17104996)
20. Wahlund LO, Barkhof F, Fazekas F, et al. European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318-1322.
21. Kapeller P, Barber R, Vermeulen RJ, et al. European Task Force of Age Related White Matter Changes. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke. 2003;34(2):441-445. doi:10.161/01.STR.04976.26453.E9
22. Scheltens P, Erkinjunti T, Leys D, et al. European Task Force on Age-Related White Matter Changes. White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol. 1998;39(2):80-89. doi:10.159/07921
23. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing; diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967-972. PubMed doi:10.136/jnp.5.10.967
24. Scheltens P, Launer LJ, Barkhof F, et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242(9):557-560. doi:10.107/BF086807
25. Pasquier F, Leys D, Weerts JG, et al. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268-272. doi:10.159/017270 (Pubitemid 26261656)
26. Scheltens P, Pasquier F, Weerts JG, et al. Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol. 1997;37(2):95-99. doi:10.159/017417 (Pubitemid 27077809)
27. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998; 316(7139):1236-1238.
28. Prudic J, Haskett RF, Mulsant BH, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153(8):985-992. (Pubitemid 26264697)
29. Dombrovski AY, Mulsant BH, Haskett RF, et al. Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry. 2005;66(8):1043-1049. doi:10.408/JCP.v6n0813 (Pubitemid 41191798)
30. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976; 218-222.
31. Beneke M, Rasmus W. "Clinical Global Impressions" (ECDEU): some critical comments. Pharmacopsychiatry. 1992;25(4):171-176. doi:10.105/s-207- 101401
32. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry. 2000;48(8):791-800. doi:10.1016/S06-323(0)094-X
33. MacQueen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A. 2003;100(3):1387-1392. doi:10.1073/pnas.0374810 (Pubitemid 36184011)
34. Parker G, Roy K, Hadzi-Pavlovic D, et al. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord. 1992;24(1):17-24. doi:10.1016/0165-0327(92)9056-C
35. Brodaty H, Hickie I, Mason C, et al. A prospective follow-up study of ECT outcome in older depressed patients. J Affect Disord. 2000;60(2):101-111. doi:10.1016/S0165-0327(9)0169-X
36. Vaidya VA, Siuciak JA, Du F, et al. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience. 1999;89(1): 157-166. doi:10.1016/S0306-452(98)0289-9 (Pubitemid 29049035)
37. Altar CA, Whitehead RE, Chen R, et al. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry. 2003;54(7):703-709. doi:10.1016/S06-323(03)073-8 (Pubitemid 37281386)
38. Duman RS, Vaidya VA. Molecular and cellular actions of chronic electroconvulsive seizures. J ECT. 1998;14(3):181-193. (Pubitemid 28433914)
39. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328(3):261-264. doi:10.1016/S0304-3940(02)0529-3 (Pubitemid 34876661)
40. Marano CM, Phatak P, Vemulapalli UR, et al. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry. 2007;68(4):512-517. doi:10.408/JCP.v68n0404 (Pubitemid 46663032)
41. Yu H, Zhang Z, Shi Y, et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry. 2008;69(7):1104-1111. doi:10.408/JCP.v69n0710 (Pubitemid 352031594)
42. Borroni B, Archetti S, Costanzi C, et al. Role of BDNF Val66 Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging 2009;30(9):1406-1412.